ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MRTX announcements Mirati Therapeutics, Inc. announcements and dividends declared NASDAQ

Mirati Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Mirati Therapeutics, Inc. MRTX

Mirati Therapeutics, Inc. MRTX listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Mirati Therapeutics, Inc. MRTX

Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to .8 billion
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to .8 billion
Announcement as on 08 October 2023

: Mirati Therapeutics shares fall after lung cancer drug gets negative opinion from European regulators
Shares of Mirati Therapeutics Inc. MRTX were down 4.7% premarket on Friday after the company said the European Medicines Agency had issued a negative opinion on a marketing application for Krazati, a treatment for non-small cell lung cancer. “Mirati disa
Announcement as on 21 July 2023

Mirati Therapeutics gets a Breakthrough designation for its colorectal cancer drug
Shares of Mirati Therapeutics Inc. jumped 6.0% in premarket trading on Thursday after the company said the Food and Drug Administration granted a breakthrough therapy designation to Krazati as a treatment for colorectal cancer. The drug is already approve
Announcement as on 22 December 2022

What's Next For Mirati Therapeutics Stock After A 20% Rise In A Month?
Mirati Therapeutics stock (NASDAQ: MRTX) has risen a solid 20% in a month, outperforming the broader markets with the S&P500 down 6%. The recent rally in MRTX stock was led by its positive findings from an early-stage clinical trial of Adagrasib, a treatme
Announcement as on 30 June 2022

Announcements by Mirati Therapeutics, Inc. first page |

MRTX Mirati Therapeutics, Inc. current price & indicator signals

Moving Averages for Mirati Therapeutics, Inc.

  • 5Day Average: 58.83
  • 12Day Average: 58.98
  • 20Day Average: 58.95
  • 50Day Average: 57.82
  • 100Day Average: 52.63
  • 150Day Average: 46.89
  • 200Day Average: 45.68

MRTX Indicators & signals

Indicator MACD (12,26,9)

58.89, 58.55, 0.48
Indicator MACD is in positive zone

Indicator ADX (14)

12.5, 20.93, 16.28
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 70
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MRTX Mirati Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Mon Jan 2024 58.70 58.54 to 58.99 -0.17% 15.1 times
19 Fri Jan 2024 58.80 58.64 to 59.15 -0.03% 1.49 times
18 Thu Jan 2024 58.82 58.80 to 58.92 -0.08% 0.23 times
17 Wed Jan 2024 58.87 58.75 to 59.25 -0.19% 0.4 times
16 Tue Jan 2024 58.98 58.97 to 59.27 -0.51% 3.36 times
12 Fri Jan 2024 59.28 58.85 to 59.46 0% 0.47 times
12 Fri Jan 2024 59.28 58.85 to 59.46 0.66% 0.47 times
11 Thu Jan 2024 58.89 58.84 to 59.04 -0.02% 0.44 times
10 Wed Jan 2024 58.90 58.82 to 59.11 -0.24% 0.54 times
09 Tue Jan 2024 59.04 58.84 to 59.20 -0.08% 2 times
08 Mon Jan 2024 59.09 58.90 to 59.40 -0.02% 0.61 times
05 Fri Jan 2024 59.10 58.75 to 59.35 0.31% 0.94 times

Videos related to: MRTX announcements Mirati Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MRTX announcements Mirati Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top